Ovid Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Ovid Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Ovid Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ovid Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $199k | 62k | 3.22 |
| 2023-09-30 | $218k | 57k | 3.84 |
| 2023-06-30 | $217k | 66k | 3.28 |
| 2023-03-31 | $29k | 11k | 2.58 |
| 2022-12-31 | $28k | 15k | 1.86 |
| 2022-06-30 | $94k | 44k | 2.15 |
| 2022-03-31 | $143k | 45k | 3.15 |
| 2021-12-31 | $158k | 49k | 3.20 |
| 2021-09-30 | $328k | 98k | 3.37 |
| 2021-03-31 | $3.0M | 752k | 4.02 |
| 2020-12-31 | $1.1M | 475k | 2.31 |
| 2020-09-30 | $296k | 52k | 5.74 |
| 2020-06-30 | $845k | 115k | 7.37 |
| 2019-12-31 | $355k | 86k | 4.15 |
| 2019-09-30 | $116k | 36k | 3.23 |
| 2019-06-30 | $87k | 47k | 1.86 |
| 2019-03-31 | $42k | 24k | 1.79 |
| 2018-12-31 | $38k | 16k | 2.43 |
| 2018-09-30 | $153k | 27k | 5.68 |
| 2018-03-31 | $105k | 15k | 7.06 |
| 2017-06-30 | $923k | 88k | 10.50 |